Safety assessment of peroxide antimalarials: clinical and chemical perspectives.
Park
B K
BK
Department of Pharmacology and Therapeutics, University of Liverpool.
O'Neill
P M
PM
Maggs
J L
JL
Pirmohamed
M
M
D000818:Animals; D000962:Antimalarials / Q000009:adverse effects* / Q000627:therapeutic use / Q000633:toxicity; D037621:Artemisinins; D001711:Biotransformation; D005290:Ferric Compounds / Q000378:metabolism; D006801:Humans; D008288:Malaria / Q000188:drug therapy; D010545:Peroxides / Q000009:adverse effects* / Q000627:therapeutic use / Q000633:toxicity; D012717:Sesquiterpenes / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D016896:Treatment Outcome
D000962:Antimalarials; D037621:Artemisinins; D005290:Ferric Compounds; D010545:Peroxides; D012717:Sesquiterpenes; C031327:artemisinin